EUCTR2020-004245-37-IE
Active, not recruiting
Phase 1
Randomised Placebo-Controlled Trial of Early Targeted Treatment of Patent Ductus Arteriosus with Paracetamol in Extremely Low Birth Weight Infants (ETAPA) - ETAPA
niversity College Dublin0 sites218 target enrollmentOctober 30, 2020
DrugsParacetamol
Overview
- Phase
- Phase 1
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- niversity College Dublin
- Enrollment
- 218
- Status
- Active, not recruiting
- Last Updated
- 5 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •\-They are inborn or transferred to a participating centre after birth and have a birth weight of \<1000g established by weight assessment on admission to NICU.
- •\-The treating doctors plan to offer them intensive care.
- •\-Large PDA is present on fnECHO, defined as PDA with diameter greater than 1\.5mm with non\-restrictive flow (defined as diastolic flow less than 50% of systolic flow)(25\), determined by targeted fnECHO between 6 and 12 hours of age.
- •Are the trial subjects under 18? yes
- •Number of subjects for this age range: 218
- •F.1\.2 Adults (18\-64 years) no
- •F.1\.2\.1 Number of subjects for this age range
- •F.1\.3 Elderly (\>\=65 years) no
- •F.1\.3\.1 Number of subjects for this age range
Exclusion Criteria
- •\-Infants with major congenital anomalies including neural tube defects, major structural cardiac anomalies (excluding PDA/ASD/PFO), abdominal wall defects and congenital diaphragmatic hernia and major dysmorphic features with an abnormal karyotype e.g. T21, T13, T18\.
- •\-The treating clinician does not intend to offer the infant intensive care.
- •\-Bidirectional shunt of PDA on ECHO (defined as shunt exceeding 30% of the right to left proportion of the shunting).
- •\-Grade II – IV IVH on point of care CRUSS on screening (between six to twelve hours of age).
- •\-PH prior to study commencement.
- •\-Severe PPHN.
- •\-History or examination suggestive of liver failure prior to study commencement.
- •\-Written informed consent has not been obtained before the infant is 12 hours of age, or the infant’s parent(s)/guardian(s) withdraw consent prior to commencement of the trial processes or assessments.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Phase 1
Research study for early treatment of Patent Ductus Arteriosus, placebo against paracetamol in extremely low birth weight infants (ETAPA)Patent Ductus ArteriosusMedDRA version: 20.0Level: PTClassification code 10034130Term: Patent ductus arteriosusSystem Organ Class: 10010331 - Congenital, familial and genetic disordersTherapeutic area: Diseases [C] - Congenital, Hereditary, and Neonatal Diseases and Abnormalities [C16]EUCTR2020-004245-37-CZniversity College Dublin218
Completed
Not Applicable
A Randomized Placebo-controlled Trial of an Early Interventional Treatment with Mometasone Furoate Nasal Spray in Japanese Cedar/Cypress PollinosisJapanese cedar/cypress pollinosisJPRN-UMIN000005985Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences50
Active, not recruiting
Phase 1
A Randomised Controlled Trial of Early Intervention in Patients HospItalised with COVID-19: Favipiravir verses HydroxycholorquiNe & Azithromycin & Zinc vErsEs Standard CaReCOVID-19 InfectionMedDRA version: 20.0Level: LLTClassification code 10051905Term: Coronavirus infectionSystem Organ Class: 100000004862Therapeutic area: Diseases [C] - Respiratory Tract Diseases [C08]EUCTR2020-001449-38-GBChelsea and Westminster Hospital NHS Foundation Trust450
Not yet recruiting
Phase 2
Effect of Early initiation of breast milk fortificatioHealth Condition 1: P788- Other specified perinatal digestive system disordersCTRI/2024/03/064394Post garduate institute of medical science and reaserch,Chandigarh
Not yet recruiting
Not Applicable
A Study of Lying Face Down to Help Improve Oxygen Levels of Adults Not Needing Ventilators in Intensive Care with COVID-19COVID-19SARS-CoV-2Respiratory - Other respiratory disorders / diseasesInfection - Other infectious diseasesACTRN12620000740998Royal Prince Alfred Hospital20